Table 1.

Experimental time course and injection sites of BDA in each monkey whose data were used in this manuscript

NameInjected sideSide to lesionDays to injectionSurvival time after injection (d)Total survival time (d)N of tracksN of injection sitesInjectionInjected amount (μl/site)
DiRightContra155752306151.5, 3.00.5
4.5
ToRightContra5631146778201.5, 3.00.5
4.5
AlRightContra278933717181.5, 3.00.5
4.5
GrRightContra2771784556121.5, 3.00.5
4.5
DeLeftIpsi10742149483.5, 5.00.5
AsLeftIpsi12430154483.5, 5.00.5
FuLeftIpsi7311398707182.0, 5.00.5
8
Mo1Right1045152.0, 4.0
6
Mo2Right1035152.0, 4.0
6
Mo3Right804122.0, 4.0
6
Mo4Right927212.0, 4.0
6
Mo5Right945152.0, 4.0
6
  • A 0.5-μl solution of biotinylated dextran amine [BDA; Molecular Probes, 10,000 MW, 10% dissolved in 0.01% phosphate buffer (pH 7.3)] was injected using a 10-μl Hamilton microsyringe. d: day.